Medication Information Sheet Student Name: ____________________________Date: ___________ Patient Initials: _________ Generic Name: clopidogrel bisulfate Trade

Name:Plavix Pronunciation: (clo-pi'do-grel) Classification / Therapeutic use of Medication:antiplatelet

Patient Dose Pt. Route Pt. Frequency of Administration

Source/Page #Online
Time/s Due (PNC shift)

Recommended Route & Dosage Maximum Safe Daily Dose or dosage range

Secondary Prevention Adult: PO 75 mg daily

Acute Coronary Syndrome (Non-ST Elevation) Adult: PO 300 mg loading dose then 75 mg daily (use with aspirin)

Uses: Why is your patient getting this medication related to their diagnosis and/or condition? Oral

Administration Considerations

Do not administer to persons with active pathologic bleeding. Discontinue drug 7 days prior to surgery. Store at 1530 C (5986 F) in tightly closed container and protect from light.

Contraindications or Cautious Use Hypersensitivity to clopidogrel; intracranial hemorrhage, peptic ulcer, or any other active pathologic bleeding. Discontinue clopidogrel 7 days before surgery and during lactation. Safety and efficacy not established in children.

Interactions: Is this medication incompatible with any medications, OTCs, herbals or foods? _______No ___x__Yes Explain: Drug: NSAIDS may increase risk of bleeding events.

Herbal: Garlic, ginger, ginkgo, evening primrose oil may increase risk of bleeding. CAUTIOUS USE Concurrent use with drugs that might induce gastrointestinal bleeding; GI bleeding, peptic ulcer
3.21.11; 10/10/11

Medication Information Sheet Student Name: ____________________________Date: ___________ Patient Initials: _________ disease; hepatic impairment (moderate to severe); severe renal impairment; patients at risk for increased bleeding; pregnancy ( category B).

Nursing Implications: Assessment & Drug Effects

Adverse Effects/ Side Effects (limit to ten) ADVERSE EFFECTS Body as a Whole: Flu-like syndrome, fatigue, pain, arthralgia, back pain.

Assessment & Drug Effects

Carefully monitor for and immediately report S&S of GI bleeding, especially when coadministered with NSAIDs, aspirin, heparin, or warfarin. Lab tests: Periodic platelet count and lipid profile. Evaluate patients with unexplained fever or infection for myelotoxicity.

CV: Chest pain, edema, hypertension, thrombocytopenic purpura. GI: Abdominal pain, dyspepsia, diarrhea, nausea, hypercholesterolemia. Hematologic: Thrombotic thrombocytopenic purpura, epistaxis. CNS: Headache, dizziness, depression. Respiratory: URI, dyspnea, rhinitis, bronchitis, cough. Skin: Rash, pruritus.

Patient and/or Family Education Patient & Family Education

If an IV medication (IVP, IVPB) Administration Considerations:N/A

Report promptly any unusual bleeding (e.g., black, tarry stools). Avoid chronic aspirin or NSAID use unless approved by physician.

Is the IV medication incompatible with other IV drips and/or solutions: ______No _____Yes Explain:

3.21.11; 10/10/11